MII Business Summary

Microtek International Inc. (MII) operates a hardware-centric business model focused on the design and manufacture of high-precision digital imaging systems, primarily serving the medical, industrial, and professional archival sectors. The company generates revenue through two core segments: Image Scanners, which includes specialized X-ray film digitizers, non-destructive testing (NDT) equipment, and high-speed document scanners; and Optoelectronic Equipment, which focuses on optical passive devices and light source systems. MII has successfully pivoted from the low-margin consumer peripheral market to high-barrier-to-entry niches, such as digital pathology and aerospace inspection, reporting 2025 revenues of approximately NT$746 million. In the competitive landscape, MII contends with global players like Epson and Ricoh (formerly Fujitsu), as well as regional specialists such as Plustek and Avision. Within this group, MII distinguishes itself as a high-end solution provider, leveraging its proprietary software integration to maintain a specialized foothold in regulated industries. The company was founded in 1980 by Bobo Wang and a team of engineers, establishing itself as a pioneer in desktop scanning technology within the Hsinchu Science Park. As of March 2026, the leadership team is led by Chairman Chih Hung Hsieh and Chief Executive Officer Ching-Hui Hsieh, the latter of whom has served in the role since November 2019. The executive team is characterized by extreme stability, with an average board tenure exceeding 23 years, reflecting a deeply institutionalized knowledge of optical engineering. Key leadership focuses on expanding the company's footprint in AI-assisted diagnostic imaging and automated optical inspection (AOI). While the company maintains a lean operational structure, its board remains closely aligned with long-term strategic stakeholders and industry veterans who have overseen MII’s transition into a specialized medical and industrial technology firm.